Givlaari
| Chemical Name | givosiran |
| Dosage Form | Injectable (subcutaneous; 189 mg/mL) |
| Drug Class | Oligonucleotides |
| System | Digestive |
| Company | Alnylam Pharmaceuticals Inc. |
| Approval Year | 2019 |
Indication
- Givlaari is indicated for the treatment of adults with acute hepatic porphyria (AHP).